Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

United Therapeutic (UTHR)

United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Zoetis Stock: Is ZTS Underperforming the Healthcare Sector?

Zoetis has underperformed the healthcare sector over the past year, and analysts remain moderately optimistic about the stock’s outlook.

XLV : 160.20 (+1.77%)
ZTS : 131.10 (+1.03%)
UTHR : 503.90 (+0.06%)
2 Cash-Producing Stocks to Keep an Eye On and 1 That Underwhelm

2 Cash-Producing Stocks to Keep an Eye On and 1 That Underwhelm

SFM : 73.87 (-2.47%)
COTY : 2.51 (-5.28%)
UTHR : 503.90 (+0.06%)
Why United Therapeutics (UTHR) Shares Are Sliding Today

Why United Therapeutics (UTHR) Shares Are Sliding Today

UTHR : 503.90 (+0.06%)
United Therapeutics (NASDAQ:UTHR) Misses Q4 CY2025 Revenue Estimates

United Therapeutics (NASDAQ:UTHR) Misses Q4 CY2025 Revenue Estimates

UTHR : 503.90 (+0.06%)
United Therapeutics: Q4 Earnings Snapshot

United Therapeutics: Q4 Earnings Snapshot

UTHR : 503.90 (+0.06%)
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, today announced its financial results for the quarter and year ended December 31, 2025. Full year 2025 revenues...

UTHR : 503.90 (+0.06%)
United Therapeutics (UTHR) Q4 Earnings Report Preview: What To Look For

United Therapeutics (UTHR) Q4 Earnings Report Preview: What To Look For

UTHR : 503.90 (+0.06%)
United Therapeutics Corporation to Present at the TD Cowen 46th Annual Health Care Conference

United Therapeutics Corporation (Nasdaq: UTHR ) announced today that Michael Benkowitz , President and Chief Operating Officer, will provide a company overview...

UTHR : 503.90 (+0.06%)
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2025 Financial Results Before the Market Opens on Wednesday, February 25, 2026

United Therapeutics Corporation (Nasdaq: UTHR ) announced today that it will report its fourth quarter and full year 2025 financial results before the market opens on Wednesday, February...

UTHR : 503.90 (+0.06%)
A Look Back at Therapeutics Stocks’ Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack

A Look Back at Therapeutics Stocks’ Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack

UTHR : 503.90 (+0.06%)

Barchart Exclusives

Why 1 Analyst Thinks DocuSign Stock Can Gain Over 170% in 2026
Even after a steep pullback, DocuSign could surge over 170% if it hits the $124 Street-high target set by Citizens, indicating a bold turnaround call. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar